• Violeta Mihailović-Vucinić, Branislav Gvozdenović, Vladimir Zugić, Jelica Videnović-Ivanov, Snezana Filipović, and Drasko Gostiljac.
• Klinicki centar, Beograd, Institut za plućne bolesti i tuberkulozu.
• Med. Pregl. 2005 Jan 1; 58 Suppl 1: 62-6.

IntroductionHealth-related quality of life in interstitial lung diseases, especially in sarcoidosis, has hardly received appropriate attention in clinical studies due to lack of validated methods of measurement. Until now, in patients with sarcoidosis and interstitial lung diseases, several generic and respiratory specific quality-of-life instruments were used in order to discover the most valid and reliable quality-of-life instrument. Sarcoidosis is a multi-system disease that affects quality of life in many different ways.Material And MethodsIn this study the Sarcoidosis Health Questionnaire was used to evaluate the quality of life in sarcoidosis patients. 89 biopsy positive sarcoidosis patients were analyzed (16 male, 73 female); their mean age 46.15 +/- 11.11 years. 34 (39%) patients presented with acute sarcoidosis, 53 (61%) with chronic sarcoidosis and 46 patients (51.7%) had extrapulmonary disease. In regard to treatment, 51 (57%) patients were treated with corticosteroids 18 (20%) with methotrexate and in 20 (23%) spontaneous remission was reported. All analyses were performed using the Statistical Package for Social Science Software: A probability value less than 0.01 considered being statistically significant.ResultsStatistically significant correlation was found between the sarcoidosis health questionnaire scores and chronic sarcoidosis. daily 0.001, emotional 0.014 and total 0.01. In regard to treatment, significant difference between groups was found in the domain of physical (sig 0.006) emotional (sign 0.005) and total (sign 0.001) scores.ConclusionThe first sarcoidosis specific questionnaire shows perfect correlation with the possible clinical course in patients with sarcoidosis.

9 keywords...

hide…